Passed GDP inspection by TFDA for medicinal products. (Sep. 27th, 2021)
Passed GMP inspection by TFDA for packaging and labeling of medicinal products. (Sep. 15th, 2021)
US Patent No.US11,021,483 entitled Crystalline of camphorsulfonic acid salt of Rucaparib and method of preparing of tricyclic compounds, Rucaparib and crystalline of camphorsulfonic acid salt of Rucaparib was granted on June 1, 2021.